MoneyWorks4Me

Anuh Pharma - Quaterly Results

08 Aug 2026 Evaluate
With no major difference for the quarter endedJune 2026 , the total revenue stood at Rs. 1938.10  millions.Net Profit recorded in the quarter ended June 2026 rise to 37.65% to Rs. 114.26  millions  compared to R. 83.01 millions in corresponding previous quarter.The company reported a good operating profit of 193.65 millions compared to 136.79 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1938.10 1864.79 3.93 1938.10 1864.79 3.93 7716.57 6615.15 16.65
Other Income 30.77 33.88 -9.18 30.77 33.88 -9.18 43.56 94.55 -53.93
PBIDT 193.65 136.79 41.57 193.65 136.79 41.57 660.76 703.64 -6.09
Interest 0.03 2.11 -98.58 0.03 2.11 -98.58 4.72 6.19 -23.75
PBDT 193.62 134.68 43.76 193.62 134.68 43.76 656.04 697.45 -5.94
Depreciation 24.33 25.15 -3.26 24.33 25.15 -3.26 113.82 87.39 30.24
PBT 169.29 109.53 54.56 169.29 109.53 54.56 542.22 610.06 -11.12
TAX 55.03 26.52 107.50 55.03 26.52 107.50 131.75 136.53 -3.50
Deferred Tax 13.71 1.62 746.30 13.71 1.62 746.30 -18.44 -16.52 11.62
PAT 114.26 83.01 37.65 114.26 83.01 37.65 410.47 473.53 -13.32
Equity 501.12 250.56 100.00 501.12 250.56 100.00 501.12 250.56 100.00
PBIDTM(%) 9.99 7.34 36.21 9.99 7.34 36.21 8.56 10.64 -19.50

Anuh Pharma Share Price

79.81 0.92 (1.17%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: